Representative Lisa C. McClain (R-Michigan) recently bought shares of The Clorox Company NYSE: CLX. In a filing disclosed on August 13th, the Representative disclosed that they had bought between $1,001 and $15,000 in Clorox stock on June 24th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.
Representative Lisa C. McClain also recently made the following trade(s):
- Sold $1,001 - $15,000 in shares of Autoliv NYSE: ALV on 8/4/2025.
- Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 8/4/2025.
- Sold $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 8/4/2025.
- Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/4/2025.
- Sold $1,001 - $15,000 in shares of SAP NYSE: SAP on 7/22/2025.
- Purchased $1,001 - $15,000 in shares of XPO NYSE: XPO on 7/22/2025.
- Purchased $1,001 - $15,000 in shares of Lithia Motors NYSE: LAD on 7/22/2025.
- Sold $1,001 - $15,000 in shares of Sanofi NASDAQ: SNY on 7/22/2025.
- Sold $1,001 - $15,000 in shares of Waters NYSE: WAT on 7/22/2025.
- Purchased $1,001 - $15,000 in shares of Group 1 Automotive NYSE: GPI on 7/22/2025.
Clorox Stock Up 0.5%
CLX stock traded up $0.59 during midday trading on Friday, hitting $122.17. The company's stock had a trading volume of 1,204,790 shares, compared to its average volume of 1,871,838. The company has a market cap of $14.94 billion, a PE ratio of 18.74, a P/E/G ratio of 0.98 and a beta of 0.49. The Clorox Company has a 12 month low of $117.35 and a 12 month high of $171.37. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The firm's 50-day moving average is $124.84 and its 200-day moving average is $136.49.
Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.63. The firm had revenue of $1.99 billion for the quarter, compared to analysts' expectations of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%. The company's revenue was up 4.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.82 EPS. On average, equities research analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.
Clorox Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 29th. Investors of record on Wednesday, August 13th will be given a $1.24 dividend. This is a boost from Clorox's previous quarterly dividend of $1.22. The ex-dividend date of this dividend is Wednesday, August 13th. This represents a $4.96 annualized dividend and a yield of 4.1%. Clorox's payout ratio is currently 76.07%.
Hedge Funds Weigh In On Clorox
Institutional investors and hedge funds have recently bought and sold shares of the company. OneDigital Investment Advisors LLC purchased a new stake in Clorox in the first quarter valued at $247,000. Brown Miller Wealth Management LLC purchased a new stake in Clorox in the first quarter valued at $399,000. Roman Butler Fullerton & Co. purchased a new stake in Clorox in the first quarter valued at $400,000. Wedge Capital Management L L P NC boosted its holdings in Clorox by 33.5% in the first quarter. Wedge Capital Management L L P NC now owns 28,510 shares of the company's stock valued at $4,198,000 after purchasing an additional 7,159 shares during the last quarter. Finally, Cornerstone Wealth Group LLC boosted its holdings in Clorox by 19.0% in the first quarter. Cornerstone Wealth Group LLC now owns 25,582 shares of the company's stock valued at $3,767,000 after purchasing an additional 4,085 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several research firms have recently commented on CLX. UBS Group reduced their price objective on Clorox from $150.00 to $134.00 and set a "neutral" rating for the company in a research note on Thursday, July 17th. Morgan Stanley reduced their price objective on Clorox from $150.00 to $137.00 and set an "equal weight" rating for the company in a research note on Friday, August 1st. Wells Fargo & Company upped their price objective on Clorox from $135.00 to $138.00 and gave the stock an "equal weight" rating in a research note on Friday, August 1st. JPMorgan Chase & Co. reduced their price objective on Clorox from $144.00 to $140.00 and set a "neutral" rating for the company in a research note on Friday, July 25th. Finally, Evercore ISI set a $140.00 price objective on Clorox and gave the stock an "underperform" rating in a research note on Tuesday, May 6th. Three equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $143.36.
Check Out Our Latest Report on Clorox
About Representative McClain
Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.
McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election.
Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.
Clorox Company Profile
(
Get Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.